Skip to main content

Sage Bionetworks, Ingenuity Agree to Share Pathway Data, Algorithms


Ingenuity Systems said this week that it is collaborating with Sage Bionetworks to improve the non-profit's predictive disease networks.

Under the collaboration, Sage will use the company's Ingenuity Pathway Analysis software and Ingenuity Knowledge Base to improve its predictive disease networks. In addition, Sage's web portal will link out to the Ingenuity Knowledge Base and to IPA, and Sage's content, algorithms, and predictive disease networks will be made available within Ingenuity products like IPA.

Ingenuity said that the collaboration will be of particular interest to researchers "who are working to understand the complex developments in the diagnosis, treatment, and etiology of diseases." In particular, using Sage's content and algorithms within IPA will enable users "to more rapidly identify and prioritize therapeutic targets for drug development and assess toxicity of potential drug candidates," the company said.

The collaboration with Sage marks the third partnership that Ingenuity has signed within the last month. In late October, the company announced that it was going to integrate IPA with TransMed Systems' XB Bio-Integration Suite (BI 10/22/2010). In early November, it announced an agreement with Geospiza to integrate IPA with Geospiza's Genesifter (BI 11/5/2010).

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.